Cargando…
The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases
The Cytotoxic Necrotizing Factor 1 (CNF1), a protein toxin from pathogenic E. coli, modulates the Rho GTPases, thus, directing the organization of the actin cytoskeleton. In the nervous system, the Rho GTPases play a key role in several processes, controlling the morphogenesis of dendritic spines an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920261/ https://www.ncbi.nlm.nih.gov/pubmed/24402235 http://dx.doi.org/10.3390/toxins6010270 |
_version_ | 1782303144312569856 |
---|---|
author | Travaglione, Sara Loizzo, Stefano Ballan, Giulia Fiorentini, Carla Fabbri, Alessia |
author_facet | Travaglione, Sara Loizzo, Stefano Ballan, Giulia Fiorentini, Carla Fabbri, Alessia |
author_sort | Travaglione, Sara |
collection | PubMed |
description | The Cytotoxic Necrotizing Factor 1 (CNF1), a protein toxin from pathogenic E. coli, modulates the Rho GTPases, thus, directing the organization of the actin cytoskeleton. In the nervous system, the Rho GTPases play a key role in several processes, controlling the morphogenesis of dendritic spines and synaptic plasticity in brain tissues. This review is focused on the peculiar property of CNF1 to enhance brain plasticity in in vivo animal models of central nervous system (CNS) diseases, and on its possible application in therapy. |
format | Online Article Text |
id | pubmed-3920261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-39202612014-02-11 The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases Travaglione, Sara Loizzo, Stefano Ballan, Giulia Fiorentini, Carla Fabbri, Alessia Toxins (Basel) Article The Cytotoxic Necrotizing Factor 1 (CNF1), a protein toxin from pathogenic E. coli, modulates the Rho GTPases, thus, directing the organization of the actin cytoskeleton. In the nervous system, the Rho GTPases play a key role in several processes, controlling the morphogenesis of dendritic spines and synaptic plasticity in brain tissues. This review is focused on the peculiar property of CNF1 to enhance brain plasticity in in vivo animal models of central nervous system (CNS) diseases, and on its possible application in therapy. MDPI 2014-01-07 /pmc/articles/PMC3920261/ /pubmed/24402235 http://dx.doi.org/10.3390/toxins6010270 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Travaglione, Sara Loizzo, Stefano Ballan, Giulia Fiorentini, Carla Fabbri, Alessia The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases |
title | The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases |
title_full | The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases |
title_fullStr | The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases |
title_full_unstemmed | The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases |
title_short | The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases |
title_sort | e. coli cnf1 as a pioneering therapy for the central nervous system diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920261/ https://www.ncbi.nlm.nih.gov/pubmed/24402235 http://dx.doi.org/10.3390/toxins6010270 |
work_keys_str_mv | AT travaglionesara theecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT loizzostefano theecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT ballangiulia theecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT fiorentinicarla theecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT fabbrialessia theecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT travaglionesara ecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT loizzostefano ecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT ballangiulia ecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT fiorentinicarla ecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases AT fabbrialessia ecolicnf1asapioneeringtherapyforthecentralnervoussystemdiseases |